German Health Minister Daniel Bahr, called on his Indian counterpart Ghulam Nabi Azad and appreciated India's efforts in strengthening the health sector.
The visiting dignitary, who was accompanied by a 15-member delegation, in his opening remarks mentioned about the clinical trials and the new EU directives.
The other members of the delegation also expressed their views on the compulsory licensing of drugs and expressed the hope that Indian authorities will show consistency and reliability while dealing with individual cases.
He specifically mentioned about the assistance given by KfW for the polio eradication initiative and for the preparation of design of Rashtriya Swasth Bima Yojana. He also thanked Germany for its support in Indo-German Social Security Programme.
Azad informed visiting dignitary that Indian pharma industry is a rapidly growing sector and in volume of exports, it stands at number three in the world. India produces affordable drugs of the highest quality and exports medicines to more than 200 countries and vaccines to about 150 nations across the globe.
He mentioned about the recent changes made in the Drugs and Cosmetics Act and assured the German delegation about the transparency while dealing with the cases of drug licenses.
Both sides have felt that there is a need to further discuss various pending issues on medical technologies and drug licensing, etc.